Skip to main content

Advertisement

SpringerLink
Log in

Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency

  • Short Communication
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Treatment of vitamin D deficiency for 3 months with oral cholecalciferol 5,000 IU daily was more effective than 2,000 IU daily in achieving optimal serum 25-hydroxyvitamin D (25OHD) concentrations. Optimal 25OHD serum level calculated to be 63.8 nmol/L. All parameters of muscle strength improved following administration of cholecalciferol for 3 months.

Introduction

The aim of this study was to determine the optimal dose of cholecalciferol required to achieve target serum 25OHD level ≥75 nmol/L and its relationship to both bone turnover and muscle strength.

Methods

Thirty deficient patients (serum 25OHD ≤50 nmol/L) were randomly assigned into two groups—i.e. 2,000 and 5,000 IU/day. Data were collected at baseline, at 2 and 3 months post-therapy: (a) clinical demographics, (b) dietary calcium recall, (c) physical tests of muscle function and (d) biochemistry. Statistical analysis used paired student t test and analysis of variance. Regression analysis was used to determine relationship between serum 25OHD and parathyroid hormone (PTH).

Results

Twenty-six (87%) patients completed 3 months of therapy. The percent increase in serum 25OHD (compared to baseline) was 82.7% in 2,000-IU group and 219.5% in 5,000-IU group. All participants (100%) achieved a serum 25OHD concentration >50 nmol/L; only 5 subjects (45.4%) in 2,000-IU group compared to 14 subjects (93.3%) in 5,000-IU group achieved final 25OHD concentration ≥75 nmol/L (p < 0.01). In the regression analysis, the reflexion point at which the PTH level increased above the normal range was calculated to be 63.8 nmol/L 25OHD. All parameters of muscle strength showed trends in improvements following the administration of both the 2,000 and 5,000 IU doses. No patient reported untoward side effects and no patient developed hypercalcaemia.

Conclusion

Treatment for 3 months with oral cholecalciferol 5,000 IU daily may be more effective than 2,000 IU daily in achieving optimal serum 25OHD concentrations in vitamin D-deficient patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. DeLuca HF, Zierold C (2008) Mechanisms and functions of vitamin D. Nutr Rev 56(2):4–10

    Google Scholar 

  2. Diamond T, Mason RS (2009) Understanding the importance of vitamin D for bone and systemic health. Medicine Today 10(1):18–25

    Google Scholar 

  3. Van der Mei IAF, Ponsonby A, Engelsen O et al (2007) The high prevalence of vitamin D insufficiency across Australian populations is only explained by season and latitude. Environ Heal Perspect 56(2):4–10

    Google Scholar 

  4. Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87(4):1080S–1086S

    PubMed  CAS  Google Scholar 

  5. Bischoff-Ferrari HA, Giovannucci E, Willet WC et al (2006) Estimations of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutrition 84:18–28

    CAS  Google Scholar 

  6. Wark JD (2003) Calcium supplementation: the bare bones. Aust Prescr 26(6):126–127

    Google Scholar 

  7. Ewing‐Fess E (1987) A method for checking jamar dynamometer calibration, J Hand Ther 1(1):28–32

    Google Scholar 

  8. McCarthy EK, Horvat MA, Holtsberg PA, Wisenbaker JM (2004) Repeated chair stands as a measure of lower limb strength in sexagenarian women. Journals of Gerontology Series A- Biological Sciences and Medical Science 59(11):1207–1212

    Article  Google Scholar 

  9. Hackman KL, Gagnon C, Briscoe RK et al (2010) Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting. Medical Journal Australia 192(12):686–689

    Google Scholar 

  10. Kuchuk NO, Plujim SM, van Schoor et al (2009) Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94(4):1244–1250

    Article  PubMed  Google Scholar 

  11. Prabhala A, Garg R, Dandona P (2000) Severe myopathy associated with Vitamin D deficiency in Western New York. Arch Intern Med 160:1244–1250

    Article  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department Endocrinology, St George Hospital, Level 3 Prichard Wing, Gray street, Kogarah, NSW, 2211, Australia

    T. Diamond, Y. K. Wong & T. Golombick

Authors
  1. T. Diamond
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. K. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Golombick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Diamond.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diamond, T., Wong, Y.K. & Golombick, T. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos Int 24, 1101–1105 (2013). https://doi.org/10.1007/s00198-012-1944-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-012-1944-7

Keywords

Search

Navigation